Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
Ward, K. W., Proksch, J. W., Azzarano, L. M., Mumaw, J. A., Roethke, T. J., Stelman, G. J., Walsh, M. J., Zeigler, K. S., McSurdy-Freed, J. E., Kehler, J. R, Chokshi, J., Levy, M. A., Smith, B. R.
Published in Xenobiotica (2001)
Published in Xenobiotica (2001)
Get full text
Journal Article
SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: Preclinical pharmacokinetics
WARD, K. W, PROKSCH, J. W, SALYERS, K. L, AZZARANO, L. M, MORGAN, J. A, ROETHKE, T. J, MCSURDY-FREED, J. E, LEVY, M. A, SMITH, B. R
Published in Xenobiotica (01.03.2002)
Published in Xenobiotica (01.03.2002)
Get full text
Journal Article
SB-239063, a potent and selective inhibitor of p38 map kinase : Preclinical pharmacokinetics and species-specific reversible isomerization
WARD, Keith W, PROKSCH, Joel W, AZZARANO, Leonard M, SALYERS, Kevin L, MCSURDY-FREED, Jeanelle E, MOLNAR, Tina M, LEVY, Mark A, SMITH, Brian R
Published in Pharmaceutical research (01.09.2001)
Published in Pharmaceutical research (01.09.2001)
Get full text
Journal Article
SB-242235, a selective inhibitor of p38 mitogenactivated protein kinase. I: Preclinical pharmacokinetics
Ward, K. W., Proksch, J. W., Salyers, K. L., Azzarano, L. M., Morgan, J. A., Roethke, T. J., McSurdy-Freed, J. E., Levy, M. A., Smith, B. R.
Published in Xenobiotica (01.01.2002)
Published in Xenobiotica (01.01.2002)
Get full text
Journal Article
DEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEY
WARD, Keith W, STELMAN, Gary J, MORGAN, Jayme A, ZEIGLER, Kelli S, AZZARANO, Leonard M, KEHLER, Jonathan R, MCSURDY-FREED, Jeanelle E, PROKSCH, Joel W, SMITH, Brian R
Published in Drug metabolism and disposition (01.02.2004)
Published in Drug metabolism and disposition (01.02.2004)
Get full text
Journal Article